AGP Executive Report
Last update: 6 hours agoCancer Pipeline: HUTCHMED reported that adding savolitinib to osimertinib cut the risk of progression or death by 45% and the risk of death by 32% in a Phase III trial of patients with a specific form of lung cancer resistant to prior treatment. Results were presented at ESMO and published in The New England Journal of Medicine. Hospital Technology: Daewoong Pharmaceutical’s AI-enabled bedside monitoring system is now operating across 342 beds at Ajou University Hospital, with plans to assess expansion to 1,100. It tracks vital signs and flags falls and abnormal heart rhythms. Local Access: A philanthropist-funded, 62-bed medical centre worth about N2.23 billion has opened in Edo State, Nigeria, aiming to reduce long trips for care. Health Workforce: Pulaski Tech won a $3 million federal grant to launch a physical therapist assistant program and build a healthcare simulation facility, addressing a regional training gap. Coverage Costs: A new survey finds U.S. employer health insurance costs rose 9%, with workers at small companies facing especially steep expenses.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
Pseudo-journalism: Pink-slime
